The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Dutasteride Soft Capsules Market Research Report 2024

Global Dutasteride Soft Capsules Market Research Report 2024

Publishing Date : Jun, 2023

License Type :

Report Code : 1738419

No of Pages : 94

Ask Your Query

Report Description
Table of Content

Synopsis
Global Dutasteride Soft Capsules market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dutasteride Soft Capsules market research.

Key manufacturers engaged in the Dutasteride Soft Capsules industry include Jiangsu Hengrui Pharmaceuticals Co.,ltd., GlaxoSmithKline plc, Sichuan Gowell Pharmaceutical Co., Ltd., Puracap Pharmaceuticals, Qilu Pharmaceutical Co., Ltd, Rivopharm UK Ltd, DM Pharma Marketing Pvt Ltd and Mega Lifesciences, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Dutasteride Soft Capsules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Dutasteride Soft Capsules market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dutasteride Soft Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

Jiangsu Hengrui Pharmaceuticals Co.,ltd.
GlaxoSmithKline plc
Sichuan Gowell Pharmaceutical Co., Ltd.
Puracap Pharmaceuticals
Qilu Pharmaceutical Co., Ltd
Rivopharm UK Ltd
DM Pharma Marketing Pvt Ltd
Mega Lifesciences

Segment by Type

Generic Drugs
Original Drugs

Segment by Application

Hospital
Clinic
Other

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Dutasteride Soft Capsules report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Dutasteride Soft Capsules Market Overview
1.1 Product Overview and Scope of Dutasteride Soft Capsules
1.2 Dutasteride Soft Capsules Segment by Type
1.2.1 Global Dutasteride Soft Capsules Market Value Comparison by Type (2023-2029)
1.2.2 Generic Drugs
1.2.3 Original Drugs
1.3 Dutasteride Soft Capsules Segment by Application
1.3.1 Global Dutasteride Soft Capsules Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Dutasteride Soft Capsules Market Size Estimates and Forecasts
1.4.1 Global Dutasteride Soft Capsules Revenue 2018-2029
1.4.2 Global Dutasteride Soft Capsules Sales 2018-2029
1.4.3 Global Dutasteride Soft Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dutasteride Soft Capsules Market Competition by Manufacturers
2.1 Global Dutasteride Soft Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dutasteride Soft Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dutasteride Soft Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Dutasteride Soft Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Dutasteride Soft Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dutasteride Soft Capsules, Product Type & Application
2.7 Dutasteride Soft Capsules Market Competitive Situation and Trends
2.7.1 Dutasteride Soft Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dutasteride Soft Capsules Players Market Share by Revenue
2.7.3 Global Dutasteride Soft Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dutasteride Soft Capsules Retrospective Market Scenario by Region
3.1 Global Dutasteride Soft Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dutasteride Soft Capsules Global Dutasteride Soft Capsules Sales by Region: 2018-2029
3.2.1 Global Dutasteride Soft Capsules Sales by Region: 2018-2023
3.2.2 Global Dutasteride Soft Capsules Sales by Region: 2024-2029
3.3 Global Dutasteride Soft Capsules Global Dutasteride Soft Capsules Revenue by Region: 2018-2029
3.3.1 Global Dutasteride Soft Capsules Revenue by Region: 2018-2023
3.3.2 Global Dutasteride Soft Capsules Revenue by Region: 2024-2029
3.4 North America Dutasteride Soft Capsules Market Facts & Figures by Country
3.4.1 North America Dutasteride Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dutasteride Soft Capsules Sales by Country (2018-2029)
3.4.3 North America Dutasteride Soft Capsules Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dutasteride Soft Capsules Market Facts & Figures by Country
3.5.1 Europe Dutasteride Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dutasteride Soft Capsules Sales by Country (2018-2029)
3.5.3 Europe Dutasteride Soft Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dutasteride Soft Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Dutasteride Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dutasteride Soft Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Dutasteride Soft Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dutasteride Soft Capsules Market Facts & Figures by Country
3.7.1 Latin America Dutasteride Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dutasteride Soft Capsules Sales by Country (2018-2029)
3.7.3 Latin America Dutasteride Soft Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dutasteride Soft Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Dutasteride Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dutasteride Soft Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dutasteride Soft Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dutasteride Soft Capsules Sales by Type (2018-2029)
4.1.1 Global Dutasteride Soft Capsules Sales by Type (2018-2023)
4.1.2 Global Dutasteride Soft Capsules Sales by Type (2024-2029)
4.1.3 Global Dutasteride Soft Capsules Sales Market Share by Type (2018-2029)
4.2 Global Dutasteride Soft Capsules Revenue by Type (2018-2029)
4.2.1 Global Dutasteride Soft Capsules Revenue by Type (2018-2023)
4.2.2 Global Dutasteride Soft Capsules Revenue by Type (2024-2029)
4.2.3 Global Dutasteride Soft Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Dutasteride Soft Capsules Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dutasteride Soft Capsules Sales by Application (2018-2029)
5.1.1 Global Dutasteride Soft Capsules Sales by Application (2018-2023)
5.1.2 Global Dutasteride Soft Capsules Sales by Application (2024-2029)
5.1.3 Global Dutasteride Soft Capsules Sales Market Share by Application (2018-2029)
5.2 Global Dutasteride Soft Capsules Revenue by Application (2018-2029)
5.2.1 Global Dutasteride Soft Capsules Revenue by Application (2018-2023)
5.2.2 Global Dutasteride Soft Capsules Revenue by Application (2024-2029)
5.2.3 Global Dutasteride Soft Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Dutasteride Soft Capsules Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
6.1.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
6.1.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
6.1.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Product Portfolio
6.1.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
6.2 GlaxoSmithKline plc
6.2.1 GlaxoSmithKline plc Corporation Information
6.2.2 GlaxoSmithKline plc Description and Business Overview
6.2.3 GlaxoSmithKline plc Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GlaxoSmithKline plc Dutasteride Soft Capsules Product Portfolio
6.2.5 GlaxoSmithKline plc Recent Developments/Updates
6.3 Sichuan Gowell Pharmaceutical Co., Ltd.
6.3.1 Sichuan Gowell Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Sichuan Gowell Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Product Portfolio
6.3.5 Sichuan Gowell Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Puracap Pharmaceuticals
6.4.1 Puracap Pharmaceuticals Corporation Information
6.4.2 Puracap Pharmaceuticals Description and Business Overview
6.4.3 Puracap Pharmaceuticals Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Puracap Pharmaceuticals Dutasteride Soft Capsules Product Portfolio
6.4.5 Puracap Pharmaceuticals Recent Developments/Updates
6.5 Qilu Pharmaceutical Co., Ltd
6.5.1 Qilu Pharmaceutical Co., Ltd Corporation Information
6.5.2 Qilu Pharmaceutical Co., Ltd Description and Business Overview
6.5.3 Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Product Portfolio
6.5.5 Qilu Pharmaceutical Co., Ltd Recent Developments/Updates
6.6 Rivopharm UK Ltd
6.6.1 Rivopharm UK Ltd Corporation Information
6.6.2 Rivopharm UK Ltd Description and Business Overview
6.6.3 Rivopharm UK Ltd Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Rivopharm UK Ltd Dutasteride Soft Capsules Product Portfolio
6.6.5 Rivopharm UK Ltd Recent Developments/Updates
6.7 DM Pharma Marketing Pvt Ltd
6.6.1 DM Pharma Marketing Pvt Ltd Corporation Information
6.6.2 DM Pharma Marketing Pvt Ltd Description and Business Overview
6.6.3 DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Product Portfolio
6.7.5 DM Pharma Marketing Pvt Ltd Recent Developments/Updates
6.8 Mega Lifesciences
6.8.1 Mega Lifesciences Corporation Information
6.8.2 Mega Lifesciences Description and Business Overview
6.8.3 Mega Lifesciences Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mega Lifesciences Dutasteride Soft Capsules Product Portfolio
6.8.5 Mega Lifesciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dutasteride Soft Capsules Industry Chain Analysis
7.2 Dutasteride Soft Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dutasteride Soft Capsules Production Mode & Process
7.4 Dutasteride Soft Capsules Sales and Marketing
7.4.1 Dutasteride Soft Capsules Sales Channels
7.4.2 Dutasteride Soft Capsules Distributors
7.5 Dutasteride Soft Capsules Customers
8 Dutasteride Soft Capsules Market Dynamics
8.1 Dutasteride Soft Capsules Industry Trends
8.2 Dutasteride Soft Capsules Market Drivers
8.3 Dutasteride Soft Capsules Market Challenges
8.4 Dutasteride Soft Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Medical Coatings Market - Industry Trends and Forecast to 2031

Global Pediatric MRI Systems Market Research Report 2024

Global Oridonin Market Research Report 2024

Global Dual Fetal Monitors Market Research Report 2024

Global Animal Examination Otoscopes Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}